|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9420 EUR | +2.39% |
|
+3.52% | +58.05% |
| 06-11 | Triple update for Biosynex |  |
| 06-10 | An undisclosed buyer acquired Entire internal molecular biology business from Biosynex SA for ?4 million. | CI |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | - | - | - | - | - | 19.31M | |
| -.--% | -.--% | -50.83x | -78.32x | 15.33x | -112.17x | -51.04x | 19.54B | |
| 1.54% | 1.62% | 16.79x | 1.82x | 1.9x | 7.92x | 11.55x | 9.39B | |
| -.--% | -.--% | -57.04x | 7.36x | 8.79x | -74.8x | -46.58x | 5.87B | |
| 2.77% | 3.22% | 20.78x | 3.8x | 7.15x | 16.14x | 17.47x | 5.61B | |
| -.--% | -.--% | 157.93x | 6.48x | 3.93x | 25.7x | 70.09x | 4.39B | |
| 1.97% | 2.06% | 19.26x | 2.01x | 3.43x | 10.65x | 14.74x | 4.03B | |
| 4.06% | 4.5% | 15.79x | 1.91x | - | - | - | 2.66B | |
| 3.57% | 3.02% | 33.34x | 1.19x | - | - | - | 1.24B | |
| 1.3% | 1.48% | 23.42x | 1.4x | 3.5x | 10.82x | 16.95x | 1.19B | |
| 1.45% | 2.13% | 15.53x | 2.56x | 3.61x | 9.27x | 10.43x | 941M | |
| Average | 1.66% | 1.8% | 19.50x | -4.98x | 5.95x | -13.31x | 5.45x | 4.99B | |
| Weighted average by Cap. | 1.02% | 1.11% | -2.88x | -25.55x | 8.78x | -44.92x | -13.10x |
- Stock Market
- Stocks
- ALBIO Stock
- Sector Biosynex
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
